There may be a genetic basis to CAD and that CXCL5 may be of therapeutic interest
Reporter: Aviva Lev-Ari, PhD, RN
It may be possible to develop a drug that mimics the effects of CXCL5 or that increases the body’s natural CXCL5 production to help prevent CAD in people at high risk. The protein could even potentially be leveraged to develop a new, nonsurgical approach to help clear clogged arteries.
New Study Suggests Protein Could Protect Against Coronary Artery Disease
Leave a Reply